Malekeh Amini, an engineer by trade, formed Trayt, after her son was diagnosed with a brain-based disorder.

Omar Ford

April 24, 2018

2 Min Read
HBS Mom Forms Company to Tackle Brain-Based Disorders Through Data Analytics
Courtesy of Trayt

What do you do when you have a child that’s suffering from a neurological disorder and nothing seems to work? What do you do when each visit to the doctor leads to more questions and more confusions.

It’s a scenario that no mother wants to go through, yet Malekeh Amini found herself in with her son.

“He was diagnosed with one neurological disorder at the age of 5, then another when he was six and another,” Amini told MD+DI. “It just continued to become more and more complex. After running around from one clinic to another and not knowing how to manage his symptoms and not knowing really how to treat him, I walked away completely lost and alone in the process.”

Amini, an engineer with more than 20 years in healthcare, took action by creating her own company to help develop applications that could give greater insight on patients suffering from neurological disorders.

Her firm’s name is Trayt and it has raised about $2 million in funding. The Red Wood City, CA-based company has just launched the Trayt app, a track-and-map application for parents, caregivers, and physicians that collects and analyzes comprehensive, individualized health data to facilitate a more rapid and relevant response to the daily challenges that confront patients with brain-based disorders.

“I really took this approach of wanting to understand patients holistically,” she said. “I wanted to know what was really wrong with my son and how I would take care of him given all of the different conditions he had and all of the different medications he was on.”

The Trayt app guides parents and caregivers to measure a patient’s symptoms in terms of intensity, frequency, and duration. Trayt then analyzes the data and provides progress reports and personalized, actionable information through a simple dashboard. Working behind the scenes, Trayt’s analytic engine delivers patient insights and recommendations that provide a daily roadmap to improve long-term health, and keeps physicians and therapists up to date on the patient’s progress.

“It’s a very different model at looking at patients,” she said.

The application doesn’t need FDA clearance or approval, but rather it must be HIPPA Compliant.

“We are basically an outcome, measures and tracking tool for families,” Amini said. “If physicians want to have an actual oversight or to look at the data they have the ability to do that.”

In the future, the company Amini said the company could branch out to other disease states such as Epilepsy, Alzheimer’s disease, multiple sclerosis, and Parkinson’s.

“Once we’ve captured all of the current spectrum in brain disorders our goal is to expand into endocrinology, oncology, and other medical conditions,” she said. “All of these conditions have a similar concept of the overlapping of symptoms.”

About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like